Literature DB >> 20861039

Engineering extracellular matrix through nanotechnology.

Cassandra M Kelleher1, Joseph P Vacanti.   

Abstract

The goal of tissue engineering is the creation of a living device that can restore, maintain or improve tissue function. Behind this goal is a new idea that has emerged from twentieth century medicine, science and engineering. It is preceded by centuries of human repair and replacement with non-living materials adapted to restore function and cosmetic appearance to patients whose tissues have been destroyed by disease, trauma or congenital abnormality. The nineteenth century advanced replacement and repair strategies based on moving living structures from a site of normal tissue into a site of defects created by the same processes. Donor skin into burn wounds, tendon transfers, intestinal replacements into the urinary tract, toes to replace fingers are all examples. The most radical application is that of vital organ transplantation in which a vital part such as heart, lung or liver is removed from one donor, preserved for transfer and implanted into a patient dying of end-stage organ failure. Tissue engineering and regenerative medicine have advanced a general strategy combining the cellular elements of living tissue with sophisticated biomaterials to produce living structures of sufficient size and function to improve patients' lives. Multiple strategies have evolved and the application of nanotechnology can only improve the field. In our era, by necessity, any medical advance must be successfully commercialized to allow widespread application to help the greatest number of patients. It follows that business models and regulatory agencies must adapt and change to enable these new technologies to emerge. This brief review will discuss the science of nanotechnology and how it has been applied to this evolving field. We will then briefly summarize the history of commercialization of tissue engineering and suggest that nanotechnology may be of use in breeching the barriers to commercialization although its primary mission is to improve the technology by solving some remaining and vexing problems in its science and engineering aspects.

Entities:  

Mesh:

Year:  2010        PMID: 20861039      PMCID: PMC2988274          DOI: 10.1098/rsif.2010.0345.focus

Source DB:  PubMed          Journal:  J R Soc Interface        ISSN: 1742-5662            Impact factor:   4.118


  59 in total

1.  Localized, direct plasmid gene delivery in vivo: prolonged therapy results in reproducible tissue regeneration.

Authors:  J Bonadio; E Smiley; P Patil; S Goldstein
Journal:  Nat Med       Date:  1999-07       Impact factor: 53.440

2.  Mechanical responses of a compliant electrospun poly(L-lactide-co-epsilon-caprolactone) small-diameter vascular graft.

Authors:  Hiroyuki Inoguchi; Il Keun Kwon; Eiko Inoue; Keiichi Takamizawa; Yoshihiko Maehara; Takehisa Matsuda
Journal:  Biomaterials       Date:  2005-09-15       Impact factor: 12.479

Review 3.  Trends in imprint lithography for biological applications.

Authors:  Van N Truskett; Michael P C Watts
Journal:  Trends Biotechnol       Date:  2006-06-06       Impact factor: 19.536

4.  Biomimicking extracellular matrix: cell adhesive RGD peptide modified electrospun poly(D,L-lactic-co-glycolic acid) nanofiber mesh.

Authors:  Taek Gyoung Kim; Tae Gwan Park
Journal:  Tissue Eng       Date:  2006-02

5.  Tissue-engineered lung: an in vivo and in vitro comparison of polyglycolic acid and pluronic F-127 hydrogel/somatic lung progenitor cell constructs to support tissue growth.

Authors:  Joaquin Cortiella; Joan E Nichols; Koji Kojima; Lawrence J Bonassar; Phong Dargon; Amit K Roy; Martin P Vacant; Jean A Niles; Charles A Vacanti
Journal:  Tissue Eng       Date:  2006-05

6.  Porous chitosan-gelatin scaffold containing plasmid DNA encoding transforming growth factor-beta1 for chondrocytes proliferation.

Authors:  Ting Guo; Jianning Zhao; Jianbin Chang; Zhi Ding; Hao Hong; Jiangning Chen; Junfeng Zhang
Journal:  Biomaterials       Date:  2005-09-06       Impact factor: 12.479

7.  Axonal outgrowth on nano-imprinted patterns.

Authors:  Fredrik Johansson; Patrick Carlberg; Nils Danielsen; Lars Montelius; Martin Kanje
Journal:  Biomaterials       Date:  2005-09-06       Impact factor: 12.479

8.  Dynamic heterodimer-functionalized surfaces for endothelial cell adhesion.

Authors:  P Jeanene Willcox; Cynthia A Reinhart-King; Steven J Lahr; William F DeGrado; Daniel A Hammer
Journal:  Biomaterials       Date:  2005-08       Impact factor: 12.479

9.  Bone regeneration by modified gene-activated matrix: effectiveness in segmental tibial defects in rats.

Authors:  Masaki Endo; Shinji Kuroda; Hisatomo Kondo; Yutaka Maruoka; Keiichi Ohya; Shohei Kasugai
Journal:  Tissue Eng       Date:  2006-03

10.  Matrix-mediated gene transfer to brain cortex and dorsal root ganglion neurones by retrograde axonal transport after dorsal column lesion.

Authors:  Ana Maria Gonzalez; Martin Berry; Lydia Greenlees; Ann Logan; Andrew Baird
Journal:  J Gene Med       Date:  2006-07       Impact factor: 4.565

View more
  15 in total

Review 1.  Regulating interface science healthcare products: myths and uncertainties.

Authors:  Christopher A Bravery
Journal:  J R Soc Interface       Date:  2010-09-22       Impact factor: 4.118

2.  Translation and commercialization of regenerative medicines.

Authors:  Julia Polak; Christopher A Bravery; Catherine Prescott
Journal:  J R Soc Interface       Date:  2010-10-06       Impact factor: 4.118

3.  Microporous dermal-like electrospun scaffolds promote accelerated skin regeneration.

Authors:  Paul P Bonvallet; Bonnie K Culpepper; Jennifer L Bain; Matthew J Schultz; Steven J Thomas; Susan L Bellis
Journal:  Tissue Eng Part A       Date:  2014-03-31       Impact factor: 3.845

Review 4.  Liposomes in tissue engineering and regenerative medicine.

Authors:  Nelson Monteiro; Albino Martins; Rui L Reis; Nuno M Neves
Journal:  J R Soc Interface       Date:  2014-12-06       Impact factor: 4.118

5.  Synergistically Promoting Bone Regeneration by Icariin-Incorporated Porous Microcarriers and Decellularized Extracellular Matrix Derived From Bone Marrow Mesenchymal Stem Cells.

Authors:  Mengyang Zhou; Min Guo; Xincui Shi; Jie Ma; Shutao Wang; Shuo Wu; Weiqun Yan; Feng Wu; Peibiao Zhang
Journal:  Front Bioeng Biotechnol       Date:  2022-04-07

Review 6.  Electrospun nanofibers for regenerative medicine.

Authors:  Wenying Liu; Stavros Thomopoulos; Younan Xia
Journal:  Adv Healthc Mater       Date:  2011-12-16       Impact factor: 9.933

7.  A Novel Protocol to Generate Decellularized Bovine Spinal Cord Extracellular Matrix-Based Scaffolds (3D-dCBS).

Authors:  Yavuz E Arslan; Burcu Efe; Tugba Sezgin Arslan
Journal:  Bio Protoc       Date:  2019-10-05

8.  Electrospun Polydioxanone Loaded With Chloroquine Modulates Template-Induced NET Release and Inflammatory Responses From Human Neutrophils.

Authors:  Allison E Fetz; Shannon E Wallace; Gary L Bowlin
Journal:  Front Bioeng Biotechnol       Date:  2021-04-27

Review 9.  Cancer research by means of tissue engineering--is there a rationale?

Authors:  Raymund E Horch; Anja M Boos; Yuan Quan; Oliver Bleiziffer; Rainer Detsch; Aldo R Boccaccini; Christoph Alexiou; Jiaming Sun; Justus P Beier; Andreas Arkudas
Journal:  J Cell Mol Med       Date:  2013-10-01       Impact factor: 5.310

10.  Human neutrophil FcγRIIIb regulates neutrophil extracellular trap release in response to electrospun polydioxanone biomaterials.

Authors:  Allison E Fetz; Marko Z Radic; Gary L Bowlin
Journal:  Acta Biomater       Date:  2021-06-09       Impact factor: 10.633

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.